Exhibit 107
Calculation of Filing Fee Table
Form S-3
(Form Type)
Vaccinex, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit (2) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | Other | 490,509(3) | $5.6350 | $2,764,018.22 | 0.00014760 | $407.97 | ||||||||
| Total Offering Amounts | $2,764,018.22 | — | $407.97 | |||||||||||||
| Total Fees Previously Paid | — | — | — | |||||||||||||
| Total Fee Offsets | — | — | — | |||||||||||||
| Net Fee Due | — | — | $407.97 | |||||||||||||
| (1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered hereby such indeterminate number of additional shares of common stock, par value $0.0001 per share, of the registrant as may be issued or issuable because of stock splits, stock dividends, stock distributions, and similar transactions. |
| (2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, on the basis of the average of the high and low prices for a share of the registrant’s common stock as reported on the Nasdaq Capital Market on June 25, 2024, which date is a date within five business days of the filing of this registration statement. |
| (3) | Consists of (i) 18,113 shares of common stock issued in March 2024, (ii) 247,170 shares of common stock issuable upon the exercise of warrants issued in March 2024 and (iii) 225,226 shares of common stock issuable upon conversion of Series A Convertible Preferred Stock issued in March 2024. |